Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
62 studies found for:    "Hypoparathyroidism"
Show Display Options
Rank Status Study
21 Completed A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients
Condition: Hypoparathyroidism
Interventions: Dietary Supplement: amorphous calcium carbonate;   Dietary Supplement: crystalline calcium supplements
22 Recruiting Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism
Condition: Hypoparathyroidism
Interventions: Drug: 25mcg rhPTH(1-84);   Drug: 50mcg rhPTH(1-84);   Drug: 100mcg rhPTH(1-84)
23 Active, not recruiting HEXT (Hypo Studies EXTended)
Condition: Hypoparathyroidism
Intervention: Drug: open-label PTH(1-84)
24 Unknown  Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy
Conditions: Hypocalcemia;   Hypoparathyroidism;   Vitamin D Deficiency;   Thyroidectomy
25 Completed Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test After Total Thyroidectomy
Condition: Hypoparathyroidism
26 Active, not recruiting Parathyroid and Thymus Transplantation in DiGeorge #931
Conditions: DiGeorge Syndrome;   Hypoparathyroidism;   Complete DiGeorge Syndrome
Intervention: Biological: Thymus/Parathyroid Transplantation
27 Completed Physiologic Regulation of FGF-23
Condition: Hypoparathyroidism
28 Completed Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
Conditions: Hypoparathyroidism;   Tetralogy of Fallot;   Pulmonary Valve Stenosis;   Conotruncal Cardiac Defects;   Heart Defects, Congenital;   Pulmonary Atresia
Interventions: Drug: calcium gluconate;   Drug: sodium citrate
29 Completed
Has Results
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
Conditions: Osteoporosis;   Osteopenia;   Vitamin D Deficiency;   Hypoparathyroidism;   Hypercalciuria;   Hypercalcemia
Intervention: Drug: Vitamin D
30 Active, not recruiting Phase I/II Thymus Transplantation With Immunosuppression #950
Conditions: DiGeorge Anomaly;   Complete DiGeorge Anomaly;   Complete Atypical DiGeorge Anomaly;   Complete DiGeorge Syndrome;   Complete Atypical DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Other: Thymus Tissue and Parental Parathyroid Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Daclizumab;   Drug: Mycophenolate mofetil
31 Active, not recruiting Thymus Transplantation Dose in DiGeorge #932
Conditions: DiGeorge Anomaly;   DiGeorge Syndrome;   Complete DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Other: Parathyroid Tissue for Transplantation
32 Recruiting Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Condition: 22q11.2 Deletion Syndrome
Interventions: Drug: NFC-1;   Drug: Placebo
33 Enrolling by invitation Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study
Condition: 22q11 Deletion Syndrome Di George Syndrome
34 Recruiting Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Chromosome Deletion;   Aneuploidy
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
35 Active, not recruiting Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome
Condition: Schizophrenia
Interventions: Other: schizophrenia;   Other: the 22q11 deletion syndrome;   Other: control group
36 Recruiting Non-Invasive Chromosomal Evaluation of 22q11.2
Condition: DiGeorge Syndrome, Velocardiofacial Syndrome, 22q.11.2 Deletion Syndrome
37 Completed Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
Conditions: Immune Defect;   22q11.2 Deletion Syndrome
38 Recruiting Whole Blood Specimen Collection From Pregnant Subjects
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Perinatal Infections
Intervention: Other: Observational - no intervention
39 Recruiting SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Conditions: 22q11 Deletion Syndrome;   DiGeorge Syndrome;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X;   Sex Chromosome Abnormalities;   Cri-du-Chat Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   1p36 Deletion Syndrome
40 Unknown  Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years